Drug Database · Clinicians

Lidocaine + Nifedipine

Also known as: lignocaine (former British name, for lidocaine)

Brands (1) AntrolinShow all

Antihemorrhoidal PH FDA category
Fixed-dose combination.

Rx · Prescription drug1 PH product
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block… US FDA label

  • Use: INDICATIONS AND USAGE Vasospastic Angina PROCARDIA XL is indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by ST segment… US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Per g rectal cream: 3 mg/15 mg

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Lidocaine + Nifedipine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Lidocaine + Nifedipine
Package insert
AntrolinNifedipine + Lidocaine hydrochloride
3 mg/15 mg per g (0.3%/1.5% w/w) Rectal Cream30 g Aluminum tube with cannula and stopper (box of 1 tube)
Rx
New.Fa.Dem. S.R.L.Italy
Bliss Pharma Distribution and Consultancy Corp.Trader: Neopharmed Gentili S.p.A.
DR-XY49677
Mar 26, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .